Overview

Fluticasone Furoate/GW642444 Inhalation Powder Long-Term Safety Study

Status:
Completed
Trial end date:
2011-05-12
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the long-term safety of fluticasone furoate/GW642444
Phase:
Phase 3
Details
Lead Sponsor:
GlaxoSmithKline
Treatments:
Fluticasone
Xhance